Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: J Mol Med (Berl). 2017 Aug 26;95(11):1237–1249. doi: 10.1007/s00109-017-1578-5

Fig. 6.

Fig. 6

Methylation of PRSS3 in association with downregulation of PRSS3 in primary liver cancer. a, b MSP analysis of PRSS3 intragenic methylation in HCC tissues. Agarose gel electrophoresis showed partial results from MSP analysis of PRSS3 intragenic methylation in human normal liver tissues (a) and primary liver cancer specimens (b). c MSP analysis of PRSS3 methylation in the specimens from human HCC patients (n = 66) or in human normal liver tissues (n = 20). The clinicopathologic data of the patients are shown in Table 1. d Correlation analysis between PRSS3 methylation and its expression in the tumor and paired adjacent tissue samples from 25 patients with primary HCC. *p < 0.05